Literature DB >> 2503341

Mass screening for colorectal cancer.

I T Khubchandani1, M C Karamchandani, F S Kleckner, J A Sheets, J J Stasik, L Rosen, R D Riether.   

Abstract

A voluntary community colorectal cancer screening project to detect occult blood in the stool of asymptomatic individuals was undertaken; 49,353 Hemoccult II kits were distributed. A total of 23,674 completed kits were returned to a central repository and processed (compliance rate, 48 percent); 851 participants had positive results (3.6 percent). Of the 640 who underwent further medical evaluation, 299 participants (46.7 percent) who had adequate follow-up had no evidence of disease. Diverse disease entities were detected in 341 participants, which was 1.4 percent of those enrolled. Forty-one patients (0.17 percent) showed significant findings that included 29 cancers (0.12 percent) and 12 (0.05 percent) noninvasive malignant polyps. Of the cancers, there were 27 colorectal, one non-Hodgkin's lymphoma, and one carcinoma of the vocal cord. In addition, 107 patients (0.45 percent) had benign polyps and 193 patients (0.82 percent) had various diseases of the gastrointestinal tract and other medical conditions. The cost of the program was modest and the results conformed to those found in previous screening surveys. The heightened public awareness of testing for colorectal disease and the detection of early lesions justifies the guaiac test screening program for mass survey.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503341     DOI: 10.1007/bf02562123

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  8 in total

Review 1.  Decision making in colorectal cancer screening.

Authors:  E Trowers; W Nguyen; E Cobos
Journal:  J Natl Med Assoc       Date:  1997-01       Impact factor: 1.798

2.  Diagnostic value of occult fecal blood testing for colorectal cancer screening.

Authors:  K Chen; D A Jiao; S Zheng; L Zhou; H Yu; Y C Yuan; K Y Yao; X Y Ma; Y Zhang
Journal:  World J Gastroenterol       Date:  1997-09-15       Impact factor: 5.742

3.  Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing.

Authors:  Charlene L Stokamer; Craig T Tenner; Jhuma Chaudhuri; Eva Vazquez; Edmund J Bini
Journal:  J Gen Intern Med       Date:  2005-03       Impact factor: 5.128

4.  Telephone reminder call in addition to mailing notification improved the acceptance rate of colonoscopy in patients with a positive fecal immunochemical test.

Authors:  Jae Myung Cha; Joung Il Lee; Kwang Ro Joo; Hyun Phil Shin; Jae Jun Park
Journal:  Dig Dis Sci       Date:  2011-06-18       Impact factor: 3.199

5.  Construction and selection of the natural immune Fab antibody phage display library from patients with colorectal cancer.

Authors:  B P Wu; B Xiao; T M Wan; Y L Zhang; Z S Zhang; D Y Zhou; Z S Lai; C F Gao
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

6.  Screening for colorectal neoplasia: physicians' adherence to complete diagnostic evaluation.

Authors:  R E Myers; A M Balshem; T A Wolf; E A Ross; L Millner
Journal:  Am J Public Health       Date:  1993-11       Impact factor: 9.308

7.  Fecal occult blood testing for colorectal cancer in an ethnically diverse population.

Authors:  G A Glober; S Hundahl; J Stucke; M Choy
Journal:  West J Med       Date:  1994-10

8.  Improving fecal occult blood testing compliance using a mailed educational reminder.

Authors:  Jeffrey K Lee; Veronica Reis; Shanglei Liu; Lorraine Conn; Erik J Groessl; Theodore G Ganiats; Samuel B Ho
Journal:  J Gen Intern Med       Date:  2009-09-23       Impact factor: 5.128

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.